Navigation Links
Treatment for fibroids with "Abortion Pill"

Women suffering form fibroids, who until now had only an option of a hysterectomy or removal of the fibroid, now have an alternative of shrinking the fibroid with the drug Mifepristone. Lead researcher Steven H. Eisinger, MD, said that fibroids are a common and vexing problem in women and fibroid relief accounts for about 30% of all hysterectomies in the U.S. Women who are symptomatic could have back pain, pain with intercourse, problems with bowels and bladder, and most especially heavy bleeding. Many of these women are also chronically// anemic.

Mifepristone was approved by the FDA in 2000 after a lot of controversies and since then studies have shown that the drug could be a possible contraceptive, a treatment for endometriosis, and a possible remedy for fibroids. Eisinger conducted a study with 20 women who all had large fibroids and multiple symptoms -- including heavy periods, pelvic pain and pressure, and lower back pain. The women were randomly asked to take either 5 mg or 10 mg of Mifepristone daily -- the very lowest doses. At the end of the study all women had a remarkable shrinkage of the fibroid, by about one-half. They also showed significant symptom relief.

An interesting fact about Mifepristone is that it stops monthly menstruation completely, giving many of these women with fibroids, who are chronically anemic, a chance to raise their blood count. They feel much better, healthier, and if they need surgery, they are much more likely to not require blood transfusion. Eisinger added that Mifepristone, compared to the currently available drug for fibroid-shrinking - Lupron (leuprolide acetate), would be cheaper and better tolerated and would work just as well. Lupron, used as a preoperative treatment to assist in the surgical removal of fibroids, decreases the body's production of estrogen to menopausal levels. Though this is useful in shrinking fibroids, side effects such as hot flashes and vaginal dryness can come with the estrog
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
(Date:7/25/2008)... WASHINGTON, July 25 /PRNewswire/ -- Klafter &...t ArthroCare Corporation ("ArthroCare" or the,"Com...s in the U.S. District,Court for the Western Distr...who purchased the common stock ArthroCare from Jan...tock Purchaser Class Period") and all,persons or e...
(Date:7/25/2008)... PLEASANTON, Calif., July 25 /PRNewswire-First...orld leader in device-based mechanical,circulatory...iling hearts,today announced that it will report ...irst six months of fiscal 2008 on Thursday, July 3...scuss its financial,results and operating activiti...
(Date:7/25/2008)..., OAK BROOK, Ill. July 25, 2008 The American S...ssued guidelines on the role of endoscopy in the b... obesity in the United States and the success in s...the number of weight-loss surgeries performed in t...he guidelines discuss endoscopy in the preoperativ...
(Date:7/25/2008)... SullivanCotter Releases Results of Fourth Annu... Survey, DETROIT, July 25 /PRNewswire/ -- S... its fourth annual survey of physician on-call pay...ay Survey Report. The survey report,with data fro...s physician,on-call pay practices and rates paid f...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3
...igh of relief for researchers at the Massachusetts...loped two robotic devices that mimic the human ank...s. Dr. Hugh Herr, Assistant Professor and Directo...e institute, has been quoted by Discovery News as ...
...edly wetter than earlier believed, a new study car...stems (RSS) has said. According to the satellite...colleagues, global temperatures have risen, but pr...ept pace. The findings also cast doubt on the abi...
...versity Comprehensive Cancer Center have discovere...more vulnerable to chronic lymphocytic leukaemia (...n greatly reduces the gene's protective activity. ... occurs later that turns the gene off altogether, ...
...day expressed concerns that the number of babies d...in Australia. The number of children dying from Su...9 in 2004 to 87 in 2005, SIDS and Kids Western Aus...le said. Doyle said education programs about safe...
Other Medicine News:Health News:Now, Natural Looking, Energy Efficient Robotic Ankles for Amputees 2Health News:World may Get Much Wetter With Global Warming Than Believed 2Health News:Gene Mutation That Increases the Risk of Chronic Lymphocytic Leukaemia Found 2
(Date:7/24/2008)... NEW ORLEANS, July 24 /PRNewswire-USNewswire/...eloped for mental illnesses, according to a new,re...cused on the,devastating effects that mental illne.... Nationwide, mental illness affects nearly 60 mil...rmaceutical Research and Manufacturers,of America ...
(Date:7/24/2008)... SOPHIA ANTIPOLIS, France, July 24 /PRNewswir...oday announced the top-line results from the 52-we...following the completion of,the 301 phase 3 study ...d,safety findings and efficacy was maintained for ... the patients, global assessment scale. In,additio...
(Date:7/23/2008)... BOSTON, July 23 /- FluoroPharma... imaging agents for the Positron Emission Tomograp...s for BFPET, its novel,Fluorine-18 labeled tracer ...harma,s second cardiovascular product to complete ...ging agent, designed to assess the blood flow in t...
(Date:7/22/2008)... BRISBANE, Australia, July 22 /PRNewswire-Fir...ded late yesterday, the Board of Progen,Pharmaceut...nced that it,had discontinued the PI-88 phase 3 st...c direction to develop its existing portfolio of c...uire additional compounds and,opportunities throug...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 1Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 2Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 3Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 4Siemens Introduces Its New Generation of Artis Interventional Imaging Systems 6856 5Human safety prosperity depend on better ocean observing system 3A Scientists 1319 1Human safety prosperity depend on better ocean observing system 3A Scientists 1319 2Human safety prosperity depend on better ocean observing system 3A Scientists 1319 3Human safety prosperity depend on better ocean observing system 3A Scientists 1319 4Human safety prosperity depend on better ocean observing system 3A Scientists 1319 5Human safety prosperity depend on better ocean observing system 3A Scientists 1319 6Human safety prosperity depend on better ocean observing system 3A Scientists 1319 7Human safety prosperity depend on better ocean observing system 3A Scientists 1319 8Age burden divorce and heavy tea consumption are significant risk factors for erosive esophagitis 6850 1Dr Dello Russo Introduces the New EYE Q Lasik 901 1
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: